Cargando…
The how’s and what’s of vaccine reactogenicity
Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760227/ https://www.ncbi.nlm.nih.gov/pubmed/31583123 http://dx.doi.org/10.1038/s41541-019-0132-6 |
_version_ | 1783453836580487168 |
---|---|
author | Hervé, Caroline Laupèze, Béatrice Del Giudice, Giuseppe Didierlaurent, Arnaud M. Tavares Da Silva, Fernanda |
author_facet | Hervé, Caroline Laupèze, Béatrice Del Giudice, Giuseppe Didierlaurent, Arnaud M. Tavares Da Silva, Fernanda |
author_sort | Hervé, Caroline |
collection | PubMed |
description | Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccination can lead to needle fear, long-term negative attitudes and non-compliant behaviours, which undermine the public health impact of vaccination. This review presents current knowledge on the potential causes of reactogenicity, and how host characteristics, vaccine administration and composition factors can influence the development and perception of reactogenicity. The intent is to provide an overview of reactogenicity after vaccination to help the vaccine community, including healthcare professionals, in maintaining confidence in vaccines by promoting vaccination, setting expectations for vaccinees about what might occur after vaccination and reducing anxiety by managing the vaccination setting. |
format | Online Article Text |
id | pubmed-6760227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-67602272019-10-03 The how’s and what’s of vaccine reactogenicity Hervé, Caroline Laupèze, Béatrice Del Giudice, Giuseppe Didierlaurent, Arnaud M. Tavares Da Silva, Fernanda NPJ Vaccines Review Article Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccination can lead to needle fear, long-term negative attitudes and non-compliant behaviours, which undermine the public health impact of vaccination. This review presents current knowledge on the potential causes of reactogenicity, and how host characteristics, vaccine administration and composition factors can influence the development and perception of reactogenicity. The intent is to provide an overview of reactogenicity after vaccination to help the vaccine community, including healthcare professionals, in maintaining confidence in vaccines by promoting vaccination, setting expectations for vaccinees about what might occur after vaccination and reducing anxiety by managing the vaccination setting. Nature Publishing Group UK 2019-09-24 /pmc/articles/PMC6760227/ /pubmed/31583123 http://dx.doi.org/10.1038/s41541-019-0132-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Hervé, Caroline Laupèze, Béatrice Del Giudice, Giuseppe Didierlaurent, Arnaud M. Tavares Da Silva, Fernanda The how’s and what’s of vaccine reactogenicity |
title | The how’s and what’s of vaccine reactogenicity |
title_full | The how’s and what’s of vaccine reactogenicity |
title_fullStr | The how’s and what’s of vaccine reactogenicity |
title_full_unstemmed | The how’s and what’s of vaccine reactogenicity |
title_short | The how’s and what’s of vaccine reactogenicity |
title_sort | how’s and what’s of vaccine reactogenicity |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760227/ https://www.ncbi.nlm.nih.gov/pubmed/31583123 http://dx.doi.org/10.1038/s41541-019-0132-6 |
work_keys_str_mv | AT hervecaroline thehowsandwhatsofvaccinereactogenicity AT laupezebeatrice thehowsandwhatsofvaccinereactogenicity AT delgiudicegiuseppe thehowsandwhatsofvaccinereactogenicity AT didierlaurentarnaudm thehowsandwhatsofvaccinereactogenicity AT tavaresdasilvafernanda thehowsandwhatsofvaccinereactogenicity AT hervecaroline howsandwhatsofvaccinereactogenicity AT laupezebeatrice howsandwhatsofvaccinereactogenicity AT delgiudicegiuseppe howsandwhatsofvaccinereactogenicity AT didierlaurentarnaudm howsandwhatsofvaccinereactogenicity AT tavaresdasilvafernanda howsandwhatsofvaccinereactogenicity |